Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis

Nephron

Volumn 72, Issue 2, 1996, Pages 145-149

  Hernandez E ^a   Praga, M ^a   Alamo, C ^a   Ataque, A ^a   Morales, J M ^a   Alcazar J M ^a   Ruilope, L M ^a   Rodicio, J L ^a  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Hemodialysis; Lipoprotein(a); Vascular access dysfunction; Vascular access survival

Indexed keywords

LIPOPROTEIN A;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; LIPOPROTEIN BLOOD LEVEL; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK FACTOR; VASCULAR ACCESS;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CATHETERS, INDWELLING; FEMALE; FOLLOW-UP STUDIES; GRAFT OCCLUSION, VASCULAR; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEIN(A); MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0030027952     PISSN: 16608151     EISSN: 22353186     Source Type: Journal    
DOI: 10.1159/000188832     Document Type: Article

References (22)

1. Berg K: A new type system in man: The Lp system. Acta Pathol Microbiol Scand 1963;59: 369-383.
2. Fless GM. Rolih CA. Scanu AM: Heterogeneity of human plasma lipoprotein(a): Isolation and characterization of the lipoprotein subspecies and their apoproteins. J Biol Chem 1984: 259:11470-11478.
3. Hixson JE. Britten ML. Manis GS, Rainwater DL: Apolipoprotein(a) glycoprotein isoforms result from size differences in apo(a) mRNA. J Biol Chem 1989:264:6013-6016.
4. McLean JW, Tomlinson JE. Kuang WJ. Eaton DL, Chien E. Fless GM, Scanu AM. Lawn RM: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987:330: 132-137.
5. Berg K. Dahlen G. Frick MH: Lp(a) lipoprotein and pre-B-lipoprotein in patients with coro-narv heart disease. Clin Genet 1974:6:230-235.
6. Murai AT. Miyahara N. Fujimoto M. Matsuda M. Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;62:249-257.
7. Rhoads GG. Dahlen G. Berg K, Morton NE, Dannenberg AL: Lp(a) lipoprotein as a risk factor for myocardial infarction. JAMA 1986:256: 2540-2544.
8. Armstrong VW, Cremer P. Eberle E, Manke A. Schulze F, Wieland IL Kreuzer IL Siedel D: The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: Dependence on serum LDL levels. Atherosclerosis 1986:62:249-257.
9. Hoff HF. Beck GJ. Skibinski CL Jurgens G. O'Neil J. Kramer J, Lytle B: Serum Lp(a) level as a predictor of vein graft stenosis after coronary bypass surgery in patients. Circulation 1988;77:1238-1244.
10. Parra HJ. Mezdour H. Cachera C, Dracon M, Tacquet A. Fruchart JC: Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis. Clin Chem 1987;33:721-724.
11. Cressman MD. O'Neil J, Heyka RJ. Paganini EP, Koch JM: Elevated lipoprotein(a) levels during chronic hemodialysis: Correlation with clinical and biochemical parameters. Circulation 1988;78(suppl II):11-364.
12. Cressman MD. Heyka RJ. Paganini EP. O'Neil J, Skibinski CL Hoff HF: Lipoprotein(a) is an independent risk factor for cardiovascular disease in hemodialysis patients. Circulation 1992:86:475-482.
13. Barbagallo CM, Avema MR, Scafidi V, Galio-ne A. Notarbartolo A: Increased lipoprotein(a) levels in subjects with chronic renal failure on hemodialysis. Nephron 1992;62:471-472.
14. Weeb AT, Reaveley DA. O'Donnell M, O'Connor B. Seed M, Brown EA: Lipoprotein(a) in patients on maintenance haemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1993:8:609-613.
15. Okura Y, Saku K, Hirata K, Zhang B. Liu R. Ogahara S. Naito S. Kajiyama G, Arakawa K: Scrum lipoprotein(a) levels in maintenance hemodialysis patients. Nephron 1993;65:46-50.
16. Thillet J. Faucher C, Issad B. Allouache M. Chapman J. Jacobs C: Lipoprotein(a) in patients treated by continuous ambulatory peritoneal dialysis. Am J Kidnev Dis 1993:22:226-232.
17. Goldwasser P. Michel MA, Collier J. Mittman N, Fein PA. Gusik SA, Avram MM: Prealbumin and lipoprotein(a) in hemodialysis: Relationships with patient and vascular access survival. Am J Kidney Dis 1993:22:215-225.
18. Hajjar KA, Gavish D. Breslow JL. Nachman RL: Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989;339:303-305.
19. Loscalzo J. Weinfeld M, Fless GM, Scanu AM: Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990:10:240-245.
20. Rath M, Niendorf A, Reblin T. Dietel M. Kreb-ber HJ. Beisiegel U: Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 1989:9:579-592.
21. Kanduossi A. Cachera C, Pagniez D. Dracon M. Fruchart JC, Tacquet A: Plasma level of lipoprotein l.p(a) is high in predialysis or hemodialysis, but not in CAPD. Kidney Int 1992; 42:424-425.
22. Cushing GL, Gaubatz JW. Nava ML. Burdick BJ, Bocan TM. Guyton JR. Weilbacher D. De-Bakey ME, Lawric GM, Morrisett JD: Quantitation and localization of apolipoprotein(a) and B in coronary artery bypass vein grafts resected at re-operation. Arteriosclerosis 1989; 9:593-603.